Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05PKR
|
||||
Former ID |
DIB020182
|
||||
Drug Name |
L-817,818
|
||||
Synonyms |
L 817818; L817818; L-817818
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [539295] | ||
Structure |
Download2D MOL |
||||
Formula |
C33H36N4O3
|
||||
InChI |
InChI=1S/C33H36N4O3/c1-21(35)20-40-33(39)29(12-6-7-17-34)36-30(38)19-28-27-16-15-23-9-4-5-11-26(23)32(27)37-31(28)25-14-13-22-8-2-3-10-24(22)18-25/h2-5,8-11,13-16,18,21,29,37H,6-7,12,17,19-20,34-35H2,1H3,(H,36,38)/t21-,29-/m0/s1
|
||||
InChIKey |
NFVRGDRCCNEGBS-LGGPFLRQSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Somatostatin receptor 1 | Target Info | Agonist | [534729] | |
Somatostatin receptor type 5 | Target Info | Agonist | [534729] | ||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathwayP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.